Dergiler / Acta Veterinaria Eurasia / 2022 / Cilt: 48 - Sayı: 2

Pharmacokinetics of Difloxacin in Probiotics-Treated Mycoplasma Gallisepticum Infected Chickens

Sayfa
87–93
Yayın Tarihi
2022-10-12
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Residue levels of difloxacin were lower in probiotic-pretreated Mycoplasma gallisepticum-infected chickens than in non-treated ones in all examined tissues

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:The impact of probiotics on difloxacin disposition in Mycoplasma gallisepticum-infected chickens after intravenous and oral administration (10 mg/kg)and its tissue residues after oral administration (10 mg/kg for 5 days) wasstudied.
📊
Temel Bulgular & Veri:Difloxacin concentrations were estimated by the high-performanceliquid chromatography method.
💡
Sonuç & Katkı:Residue levels of difloxacin were lower in probiotic-pretreated Mycoplasma gallisepticum-infected chickens than in non-treated ones in all examined tissues
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

The impact of probiotics on difloxacin disposition in Mycoplasma gallisepticum-infected chickens after intravenous and oral administration (10 mg/kg)and its tissue residues after oral administration (10 mg/kg for 5 days) wasstudied. Difloxacin concentrations were estimated by the high-performanceliquid chromatography method. Following intravenous administration of difloxacin, the volume of distribution in probiotic-pretreated Mycoplasma gallisepticum-infected chickens (4.05 ± 0.07) was less than that in non-treated birds (4.16 ± 0.07 mg/μg/mL). The t1/2β of difloxacin in probiotic-pretreated Mycoplasma gallisepticum-infected chickens (4.75 ± 0.09 hours) was significantly longer than that in the non-treated ones (4.55 ± 0.05 hours). The total body clearance of the drug from the plasma of probiotic-pretreated Mycoplasma gallisepticum-infected chickens (0.64 ± 0.00 mg/(μg/mL)/h)was less than that in non-treated ones (0.69 ± 0.01 mg/(μg/mL)/h). Thearea under the curve extrapolated to last plasma concentration0–t (15.20 ±0.08 μg/mL/h) and the mean residence time (6.33 ± 0.11 hours) values in probiotic-pretreated Mycoplasma gallisepticum-infected chickens were larger than those in non-treated ones (14.13 ± 0.22 μg/mL/h and 6.02 ± 0.06 hours). The drug was rapidly absorbed orally in probiotic-pretreatedMycoplasma gallisepticum-infected chickens compared to non-treatedones (t1/2ab 1.47 ± 0.02 vs. 1.53 ± 0.05 hours). The peak serum concentrationof difloxacin in probiotic-pretreated Mycoplasma gallisepticum-infectedchickens was higher than that in non-treated ones (1.46 ± 0.07 vs. 1.18 ± 0.07 μg/mL) and was achieved at shorter time to peak concentration (2.59 ± 0.01 vs. 2.74 ± 0.05 hours). Residue levels of difloxacin were lower in probiotic-pretreated Mycoplasma gallisepticum-infected chickens than in non-treated ones in all examined tissues

🔖

Bu Makaleye Atıf Yap

DARWISH, A., MOHAMED, H. F., MOHAMED, A., ATTA, A. H. (2022). Pharmacokinetics of Difloxacin in Probiotics-Treated Mycoplasma Gallisepticum Infected Chickens. Acta Veterinaria Eurasia, Cilt: 48 - Sayı: 2, 87–93. https://ajindex.com/articles/428032

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (3)

  1. Abo El-Ela, F. I., Radi, A. M., El-Banna, H. A., El-Gendy, A. A. M., & Tohamy, M. A. (2014). Pharmacokinetics of difloxacin in healthy and E. coli-infected broiler chickens. British Poultry Science, 55(6), 830–836. [CrossRef] Aboubakr, M., & Elbadawy, M. (2019). Pharmacokinetics of difloxacin in Japanese quails (Coturnix japonica) after single intravenous and oral administration. Research in Veterinary Science, 122, 36–39. [CrossRef] Alomar, M. J. (2014). Factors affecting the development of adverse drug reactions (Review article). Saudi Pharmaceutical Journal, 22(2), 83–94. [CrossRef] Anadón, A., Suárez, F. H., Martínez, M. A., Castellano, V., Martínez, M., Ares, I., Ramos, E., Gamboa, F., & Martínez-Larrañaga, M. R. (2011). Plasma disposition and tissue depletion of difloxacin and its metabolite sarafloxacin in the food producing animals, chickens for fattening. Food and Chemical Toxicology, 49(2), 441–449. [CrossRef] Apata, D. F. (2008). Growth performance, nutrient digestibility and immune response of broiler chicks fed diets supplemented with a culture of Lactobacillus bulgaricus. Journal of the Science of Food and Agriculture, 88(7), 1253–1258. [CrossRef] Atef, M., Atta, A. H., Darwish, A. S., & Mohamed, H. (2017). Pharmacokinetics aspects and tissue residues of marbofloxacin in healthy and Mycoplasma gallisepticum-infected chickens. Wulfenia Journal, 24(10), 80–107.
  2. Atta, A. H., & Sharif, L. (1997). Pharmacokinetics of ciprofloxacin following intravenous and oral administration in broiler chickens. Journal of Veterinary Pharmacology and Therapeutics, 20(4), 326–329. [CrossRef] Cazedey, E. C. L., Juodinis, V. D., & Salgado, H. R. N. (2014). A stability-indicating LC method for difloxacin in the presence of degradation products. World Journal of Pharmacy & Pharmaceutical Sciences, 3(9), 45–56.
  3. Cressman, A. M., Petrovic, V., & Piquette-Miller, M. (2012). Inflammation-mediated changes in drug transporter expression/activity: Implications for therapeutic drug response. Expert Review of Clinical Pharmacology, 5(1), 69–89. [CrossRef] De Keersmaecker, S. C. J., Verhoeven, T. L. A., Desair, J., Marchal, K., Vanderleyden, J., & Nagy, I. (2006). Strong antimicrobial activity of Lactobacillus rhamnosus GG against Salmonella typhimurium is due to accumulation of lactic acid. FEMS Microbiology Letters, 259(1), 89–96. [CrossRef] Ding, H., Wang, L., Shen, X., Gu, X., Zeng, D., & Zeng, Z. (2013). Plasma and tissue pharmacokinetics of marbofloxacin in expe